Cargando…
Refractory Checkpoint Inhibitor Colitis Responsive to Ustekinumab
Immune checkpoint inhibitors have transformed the treatment of cancer. Nonetheless, multiple immune-related adverse events have been reported, including checkpoint inhibitor colitis. Severe colitis can be complicated by ileus, megacolon, intestinal perforation, and death. Current appropriate treatme...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Wolters Kluwer
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9794264/ https://www.ncbi.nlm.nih.gov/pubmed/36600789 http://dx.doi.org/10.14309/crj.0000000000000946 |